Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FTY720 vs corticosteroid for acute noninfectious uveitis
2011-004160-30Phase 2Terminated
- Sponsor
- Novartis
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of fingolimod in Hyalitis, posterior uveitis, panuveitis and 1 more (2 arms), sponsored by Novartis. Primary endpoint: Vitreous haze at Day 8. Started Apr 2012; status: terminated.
02
Drugs
fingolimod
03
Conditions
Hyalitisposterior uveitispanuveitisuveitis
Beyond the preview
Go deeper on 2011-004160-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004160-30.